
About Purple MicroPort
Purple MicroPort is a Healthcare company based in Mumbai (India) founded in 2003. Cardiovascular medical devices, including stents and pacemakers, are developed. Purple MicroPort has raised $6.79 million across 1 funding round from investors including MicroPort Orthopedics. The company has 143 employees. Purple MicroPort was last valued at $20.86 million in March 2020. Its Indian entity Purple Microport Cardiovascular Private Limited reported revenue of βΉ100 Cr. Purple MicroPort offers products and services including Medical Devices, Percutaneous Coronary Intervention Devices, and Transcatheter Aortic Valve Replacement Devices. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices.
Company details
Purple MicroPort was founded in 2003 and is headquartered in Mumbai, India. Focus is placed on the medical devices sector, with operations centered on cardiovascular treatments. Products such as the Rapamycin target eluting coronary stent system, VitaFlow aortic valve, dual chamber pacemaker featuring AutoMRI technology, and cardiac resynchronization therapy defibrillators are provided to address related health needs.
- Headquarters Mumbai, India
- Employees 143
- Stage Minicorn
- SectorsHealthcare
- Website purplemicroport.com
- Legal Name Purple Microport Cardiovascular Private Limited
- Date of Incorporation 27 Aug, 2007
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹100 Cr
FY 2025 · -12% YoY
- Net Profit₹4.82 Cr
FY 2025 · 5% margin
- EBITDA₹11.43 Cr
FY 2025 · 11% margin
- Total Equity Funding$6.79M (USD)
in 1 rounds
- Latest Funding Round$6.79M (USD), Series A
Mar 2020
- Investors
- Employee Count143
Associated legal entities of Purple MicroPort
Purple MicroPort operates through Purple Microport Cardiovascular Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Purple Microport Cardiovascular Private Limited CIN U85100MH2007PTC173490 | Active | 27 Aug 2007 | Mumbai, Maharashtra | ₹100 Cr | 143 | 3 | View details |
Products & Services of Purple MicroPort
Purple MicroPort offers a comprehensive portfolio of products and services, including Medical Devices, Percutaneous Coronary Intervention Devices, and Transcatheter Aortic Valve Replacement Devices.
Tools for treating coronary artery disease and heart conditions
Devices for minimally invasive heart procedures
Equipment for valve stenosis treatments
Funding Insights of Purple MicroPort
Purple MicroPort has successfully raised a total of $6.79M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.79 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.79M
- Total Rounds 1
- Last Round Series A β $6.79M
- First Round $6.79M
(Mar 2020)
- Investors Count 1
All 1 funding rounds of Purple MicroPort with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $6.79M | Series A | $20.86M | MicroPort Orthopedics | β |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2020 | $20.86M | β’β’β’β’β’β’β’β’ |
Last known valuation $20.86M (Mar 2020). 1 investors in total: 1 institutional.
Investors in Purple MicroPort
Purple MicroPort has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MicroPort Orthopedics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of implantable devices and diagnostic solutions for multiple fields | 1998 | microport.com | Shanghai, China |
Investor details for Purple MicroPort
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Purple Microport Cardiovascular Private Limited (Purple MicroPort)
Purple Microport Cardiovascular Private Limited is the primary company behind Purple MicroPort. The board of Purple Microport Cardiovascular Private Limited currently have 3 directors; the longest-serving is Brian Savio Lancelot, appointed in 2010. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Brian Savio Lancelot DIN 02832585 | Director | 10 Jul 2010 | 16 yrs 4 mo | Purple Microport Cardiovascular Private Limited |
| Rajesh Hiralal Shrivas DIN 02783629 | Director | 10 Jul 2010 | 16 yrs 4 mo | Purple Microport Cardiovascular Private Limited |
| Jonathan W Chen DIN 08762967 | Director | 11 Nov 2021 | 5 yrs | Purple Microport Cardiovascular Private Limited |
People of Purple MicroPort
2 people are tracked at Purple MicroPort (2 in leadership); the tracked headcount is 143.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Dimple Panchal | Head- Human Resource | Leadership |
Complete people profiles for Purple MicroPort
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Purple MicroPort
Figures of Purple Microport Cardiovascular Private Limited, the primary company behind Purple MicroPort, for FY 2025. Revenue was ₹100 Cr (-12% year on year). Net profit was ₹4.82 Cr (5% margin). EBITDA was ₹11.43 Cr (11% margin). Revenue has grown at a compounded annual rate of +10% over three years and +22% over five years.
- ₹100 CrRevenue · FY 2025 · -12% YoY
- ₹4.82 CrNet profit · 5% margin
- ₹11.43 CrEBITDA · 11% margin
- ₹1.85 CrPaid-up capital
- 143Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Purple Microport Cardiovascular Private Limited are on its company page.
Detailed financial statements for Purple MicroPort
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Purple MicroPort
3 dated milestones of Purple MicroPort across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Purple MicroPort is founded.
- Funding First funding round of $6.8M.
- Milestone Reaches Minicorn status.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Purple MicroPort
Purple MicroPort was founded in 2003 and raised its 1st funding round 17 years after it was founded.
Purple MicroPort is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Purple MicroPort is a funded company, having raised a total of $6.79M across 1 funding round to date. The company's 1st funding round was a Series A of $6.79M, raised on Mar 2020.
Purple MicroPort has 143 employees.
The primary company behind Purple MicroPort, Purple Microport Cardiovascular Private Limited, reported revenue of βΉ100 Cr for FY 2025, down 12% year on year.
Purple MicroPort was founded in 2003 and is headquartered in Mumbai, India. Focus is placed on the medical devices sector, with operations centered on cardiovascular treatments. Products such as the Rapamycin target eluting coronary stent system, VitaFlow aortic valve, dual chamber pacemaker featuring AutoMRI technology, and cardiac resynchronization therapy defibrillators are provided to address related health needs.
Purple MicroPort offers Medical Devices, Percutaneous Coronary Intervention Devices, and Transcatheter Aortic Valve Replacement Devices.
Purple MicroPort has 1 investor. Key investors include MicroPort Orthopedics.
The valuation of Purple MicroPort is $20.86M as of Mar 2020.
Purple MicroPort operates through Purple Microport Cardiovascular Private Limited.
The legal entities of Purple MicroPort currently have 3 directors, including Brian Savio Lancelot, Rajesh Hiralal Shrivas, Jonathan W Chen.